CN100515466C - 一种治疗中风病的中药制剂 - Google Patents
一种治疗中风病的中药制剂 Download PDFInfo
- Publication number
- CN100515466C CN100515466C CNB2006101632339A CN200610163233A CN100515466C CN 100515466 C CN100515466 C CN 100515466C CN B2006101632339 A CNB2006101632339 A CN B2006101632339A CN 200610163233 A CN200610163233 A CN 200610163233A CN 100515466 C CN100515466 C CN 100515466C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- medicine preparation
- apoplexy
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 206010008190 Cerebrovascular accident Diseases 0.000 claims abstract description 27
- 208000006011 Stroke Diseases 0.000 claims abstract description 27
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 6
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 6
- 239000008187 granular material Substances 0.000 claims abstract description 5
- 239000006187 pill Substances 0.000 claims abstract description 4
- 239000002775 capsule Substances 0.000 claims abstract description 3
- 239000003826 tablet Substances 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 6
- 241000243684 Lumbricus Species 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims 1
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 241000207929 Scutellaria Species 0.000 abstract 1
- 241000157352 Uncaria Species 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 206010008118 cerebral infarction Diseases 0.000 description 13
- 238000000034 method Methods 0.000 description 11
- 210000004556 brain Anatomy 0.000 description 8
- 208000026106 cerebrovascular disease Diseases 0.000 description 8
- 201000006474 Brain Ischemia Diseases 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 230000002008 hemorrhagic effect Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 206010008120 Cerebral ischaemia Diseases 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 206010053567 Coagulopathies Diseases 0.000 description 3
- 208000003164 Diplopia Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 229940126678 chinese medicines Drugs 0.000 description 3
- 230000035602 clotting Effects 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 208000021760 high fever Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 2
- 229960003321 baicalin Drugs 0.000 description 2
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 208000007204 Brain death Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 238000006424 Flood reaction Methods 0.000 description 1
- 208000000386 Hypertensive Intracranial Hemorrhage Diseases 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 244000303379 Styrax officinalis Species 0.000 description 1
- 235000001361 Styrax officinalis Nutrition 0.000 description 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 231100000643 Substance intoxication Toxicity 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000004518 granules dosage form Substances 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
症状 | 例数 | 显效 | 有效 | 无效 | 有效率 |
缺血性中风 | 45 | 15 | 25 | 5 | 88.9% |
出血性中风 | 55 | 22 | 29 | 4 | 92.7% |
合计 | 110 | 37 | 54 | 9 | 91.8% |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101632339A CN100515466C (zh) | 2006-12-13 | 2006-12-13 | 一种治疗中风病的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101632339A CN100515466C (zh) | 2006-12-13 | 2006-12-13 | 一种治疗中风病的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1977952A CN1977952A (zh) | 2007-06-13 |
CN100515466C true CN100515466C (zh) | 2009-07-22 |
Family
ID=38129372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101632339A Active CN100515466C (zh) | 2006-12-13 | 2006-12-13 | 一种治疗中风病的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100515466C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101879284B (zh) * | 2010-06-23 | 2011-11-09 | 仲昭禄 | 一种治疗肝肾阴虚风阳上扰型中风的中药制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1335158A (zh) * | 2001-05-31 | 2002-02-13 | 赵文远 | 中风固本胶囊 |
-
2006
- 2006-12-13 CN CNB2006101632339A patent/CN100515466C/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1335158A (zh) * | 2001-05-31 | 2002-02-13 | 赵文远 | 中风固本胶囊 |
Non-Patent Citations (2)
Title |
---|
中药成方制剂第9册. 药典委员会,38,药典委员会. 1998 |
中药成方制剂第9册. 药典委员会,38,药典委员会. 1998 * |
Also Published As
Publication number | Publication date |
---|---|
CN1977952A (zh) | 2007-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1994451B (zh) | 治疗抑郁症的中药组合物及其制备方法和其应用 | |
CN102614387A (zh) | 预防和治疗脑中风的中药及制备方法 | |
CN100546615C (zh) | 用于治疗脑血管病的中药组合物及其制备方法 | |
CN101129588A (zh) | 结膜炎冲剂 | |
CN100586458C (zh) | 治疗脑中风病药物 | |
CN101537159B (zh) | 一种中药组合物及其制备方法和应用 | |
CN101152243B (zh) | 一种治疗中风病的中药组合物的制备工艺 | |
CN100493578C (zh) | 一种治疗体形消瘦、体质虚弱的中药组合物及其制备方法 | |
CN100335120C (zh) | 一种治疗梅核气的中成药及其制备方法 | |
CN100515466C (zh) | 一种治疗中风病的中药制剂 | |
CN105311492A (zh) | 一种用于冠状动脉粥样硬化性心脏病的药物 | |
CN104645015A (zh) | 一种治疗血管性痴呆的中药复方制剂及其制备方法 | |
CN1180821C (zh) | 一种治疗脑血栓的药物及制备方法 | |
CN104324134B (zh) | 一种改善微循环的中药组合物及其制备方法 | |
CN100409880C (zh) | 一种治疗高脂血症的蒙药保利尔及其制备方法 | |
CN1682837A (zh) | 调节血脂的药物及其制备方法 | |
CN1399999A (zh) | 一种治疗恶性肿瘤病的药物及其制备方法 | |
CN107648335B (zh) | 调节动脉粥样硬化自噬与凋亡的中药组合物及制备方法 | |
CN102228596B (zh) | 一种药物组合物及制剂及在治疗冠心病、心绞痛中的应用 | |
CN101912442A (zh) | 一种治疗上呼吸道感染的微型灌肠剂及其制备方法 | |
CN102139005B (zh) | 一种治疗心脑血管疾病的药物 | |
CN112791150A (zh) | 一种治疗颈部血管斑块的中药组合物及其制备方法 | |
CN101549140B (zh) | 治疗艾滋病的中药组合物及其制备方法 | |
CN1827138A (zh) | 一种治疗心脑血管疾病的中药组合物处方及制备工艺 | |
CN108186758A (zh) | 一种益气活血的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TONGYAO PHARMACEUTICAL GROUP STOCK CO., LTD. Free format text: FORMER OWNER: GAO LU Effective date: 20111230 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 130012 CHANGCHUN, JILIN PROVINCE TO: 134000 TONGHUA, JILIN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20111230 Address after: 134000 amendment Road 39, Jilin, Tonghua Patentee after: Tongyao Pharmaceutical Group Corporation Address before: 130012 No. 2426 Qianjin Street, Changchun hi tech Development Zone, Jilin, China Patentee before: Gao Lu |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A traditional Chinese medicine preparation for treating apoplexy Effective date of registration: 20201126 Granted publication date: 20090722 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: Tongyao Pharmaceutical Group Corp. Registration number: Y2020220000086 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211221 Granted publication date: 20090722 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: Tongyao Pharmaceutical Group Corp. Registration number: Y2020220000086 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |